Arons, E., Suntum, T., Stetler-Stevenson, M. & Kreitman, R.J. (2009) VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood, 114, 4687–4695. Callet-Bauchu, E., Baseggio, L., Felman, P., Traverse-Glehen, A., Berger, F., Morel, D., Gazzo, S., Poncet, C., Thieblemont, C., Coiffier, B., Magaud, J.P. & Salles, G. (2005) Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases. Leukemia, 19, 1818– 1823. Hockley, S.L., Giannouli, S., Morilla, A., Wotherspoon, A., Morgan, G.J., Matutes, E. & Gonzalez, D. (2010) Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns. British Journal of Haematology, 148, 666–669. Matutes, E., Wotherspoon, A. & Catovsky, D. (2003) The variant form of hairy-cell leukaemia. Best Practice & Research. Clinical Haematology, 16, 41–56. Matutes, E., Oscier, D., Montalban, C., Berger, F., Callet-Bauchu, E., Dogan, A., Felman, P., Franco, V., Iannitto, E., Mollejo, M., Papadaki, T., Remstein, E.D., Salar, A., Sole, F., Stamatopoulos, K., Thieblemont, C., Traverse-Glehen, A., Wotherspoon, A., Coiffier, B. & Piris, M.A. (2008) Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia, 22, 487–495. Swerdlow, S.H. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon. Traverse-Glehen, A., Baseggio, L., Bauchu, E.C., Morel, D., Gazzo, S., Ffrench, M., Verney, A., Rolland, D., Thieblemont, C., Magaud, J.P., Salles, G., Coiffier, B., Berger, F. & Felman, P. (2008) Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity? Blood, 111, 2253–2260.
[1]
S. Frost,et al.
Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease.
,
2007,
Blood.
[2]
E. Sagnelli,et al.
HCV genotype 2 as a risk factor for reactivation of chronic HCV infection
,
2005,
Gut.
[3]
C. la Vecchia,et al.
Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients
,
2005,
Gut.
[4]
N. Hiraga,et al.
Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum alanine aminotransferase flare‐up
,
2005,
Journal of medical virology.
[5]
K. Boudjema,et al.
Effects of corticosteroids on HCV infection.
,
1999,
International journal of immunopharmacology.
[6]
C. Chu,et al.
Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study.
,
1996,
Journal of hepatology.
[7]
R. Fagerstrom,et al.
Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease
,
1984,
Clinical genetics.
[8]
R. Blumenthal,et al.
Clinical practice. Low HDL cholesterol levels.
,
2005,
The New England journal of medicine.